In addition, recently studies showed that increased expression of AFAP1-AS1 could participate in the progression of a variety of tumors, including nasopharyngeal carcinoma, pancreatic ductal adenocarcinoma, hepatocellular carcinoma, colorectal cancer and gallbladder cancer [16-20].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}